MoneyWorks4Me

A decent increase of about 29.27% in the sales to Rs. 900.34 millions was observed for the quarter ended September 2024. The sales figure stood at Rs. 696.50 millions during the year-ago period.An average growth of 35.57% was recorded for the quarter ended September 2024 to Rs. 84.84  millions from Rs. 62.58 millions.OP of the company witnessed a marginal growth to 199.03 millions from 154.99 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 900.34 696.50 29.27 1701.13 1371.00 24.08 3071.72 2509.95 22.38
Other Income 2.22 2.34 -5.13 5.00 6.30 -20.63 18.30 29.41 -37.78
PBIDT 199.03 154.99 28.41 375.38 297.02 26.38 684.63 632.29 8.28
Interest 27.07 24.11 12.28 51.85 45.96 12.82 103.87 60.20 72.54
PBDT 171.96 130.88 31.39 323.53 251.06 28.87 509.77 406.80 25.31
Depreciation 46.13 48.77 -5.41 86.32 96.56 -10.60 195.11 149.19 30.78
PBT 125.83 82.11 53.25 237.21 154.50 53.53 314.66 257.61 22.15
TAX 40.99 19.53 109.88 68.70 37.46 83.40 74.83 62.93 18.91
Deferred Tax 0.26 -1.96 -113.27 -0.06 -2.25 -97.33 -4.37 1.37 -418.98
PAT 84.84 62.58 35.57 168.51 117.04 43.98 239.83 194.68 23.19
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 22.11 22.25 -0.66 22.07 21.66 1.86 22.29 25.19 -11.52
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..